Onderneming Briacell Therapeutics Corp Toronto S.E.
Aandelen
CA10778Y1043
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
William Williams
CEO | Chief Executive Officer | 68 | 01-11-16 |
Gadi Levin
DFI | Director of Finance/CFO | 52 | 01-02-16 |
Chief Tech/Sci/R&D Officer | 53 | 01-05-21 | |
Chief Tech/Sci/R&D Officer | 62 | 16-02-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Martin Schmieg
BRD | Director/Board Member | 62 | 10-05-16 |
Marc Lustig
BRD | Director/Board Member | 51 | 31-08-21 |
Rebecca Taub
BRD | Director/Board Member | 71 | 07-03-18 |
Director/Board Member | 66 | 18-03-19 | |
William Williams
CEO | Chief Executive Officer | 68 | 01-11-16 |
Jane Gross
BRD | Director/Board Member | 67 | 01-11-21 |
Chairman | 39 | 04-02-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 15 981 726 | 13 137 190 ( 82,20 %) | 0 | 82,20 % |
Bedrijfsgegevens
BriaCell Therapeutics Corp.
Bellevue Centre 235 -15th Street
V7T 2X1, West Vancouver
+604 921 1810
http://www.briacell.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,91% | 118 mld. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. |